Tagged biologics
Press Release
Aesthetic Management Partners Announces Exclusive Distribution Agreement With Estar Medical
Estar Medical, the maker of Eclipse PRP® and Tropocells®, has signed an exclusive long-term marketing and distribution agreement with Aesthetic Management Partners, LLC (AMP), to sell its PRP products in the U.S. market. Read More
Press Release
Isto Biologics Acquires TheraCell, Adding Additional Novel Products to Help Patients Heal Faster
The acquisition of TheraCell, Inc. will expand access for two best-in-class product portfolios and build upon Isto's continued commitment to putting patients and their surgical champions first. Read More
Press Release
SiO2 Materials Science and Doosan Corporation Enter Into Strategic Partnership to Accelerate Market Development in Asia
Companies have also entered into a joint development agreement which will merge technologies with the aim to bring innovative products for consumer electronics market. Read More
Press Release
Alliance for Stem Cell Therapy Now and American Academy of Stem Cell Physicians Hosting Safety Industry Panel
Alliance for Stem Cell Therapy Now Ms. Janet Marchibroda will moderate the Safety industry panel hosted by AASCP in Miami on November 2, 2019 and will be broadcast live. Read More
Press Release
Parametrics Medical Announces National Promotion Agreement With DePuy Synthes to Provide Allografts for Sports Medicine Repairs
Agreement further supports Parametrics' and DePuy Synthes' shared commitment to a comprehensive sports medicine procedural focus as physicians care for a broader patient population Read More
Press Release
Analysis of Over 1,000 Atopic Dermatitis Patients Highlights Moderate-to-Severe Patient Candidacy for Biologics and Small Molecules and Real-World Treatment Patterns for Patients Treated With Sanofi/Regeneron's Dupixent
Candidacy analysis for pipeline agents reveals that JAK inhibitors, such as Pfizer's PF-0496582, AbbVie's upadacitinib and Incyte's topical ruxolitinib have the most potential upside if approved Read More
Press Release
Pfizer's Xeljanz Begins to Shift the Treatment Paradigm in Ulcerative Colitis (UC) With Early Launch Metrics Largely Favorable for the Brand
The majority of patients started on Xeljanz have failed multiple biologics, but some gastroenterologists see the brand securing a role in the pre-biologic space in the near future, according to the latest quarterly report from Spherix Global Insights Read More
Press Release
Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks
At the heart of key challenges facing biologics laboratories today lies the volume and complexity of data created throughout the scientific process Read More
Press Release
Global Biosimilars Market to Aggregate $99.28 Billion by 2024 and Grow at a CAGR of 57.03% During the Forecast Period 2018-2024
Factors, such as growing incidence of cancer cases and lifestyle diseases globally, the cost-effectiveness of biosimilars over biologics, and strategic collaboration to develop new biosimilar drugs will increase the market growth during the forecast period. Read More
Press Release
Cell-Based Assays in a CGMP Environment: Approaches for Clinical and Commercial Stability Studies, New Webinar Hosted by Xtalks
Presentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP <1032> and <1033>) and are suitable for CGMP stability testing Read More
Press Release
AdvantaPure(R) Welcomes Manager for Single Use Systems; New Position Adds to Company's Expertise
High purity tubing and single use systems manufacturer AdvantaPure has appointed Tony Butler to a new position focusing on single use systems for pharmaceutical and biologics manufacturing. The role arose because of the company's continued growth. Read More
Press Release
Four Years Of The International DDI Workshop In Marbach Castle - A Real Success Story
The organisation team of the international Drug-Drug Interaction (DDI) Workshop in Marbach Castle on Lake Constance is happy to report the great acceptance and success of the events series in its fourth year. More than 70 drug development experts and Read More
Press Release